Treat and Reduce Obesity Act of 2025
Senate Bill Would Expand Medicare Obesity Coverage to More Providers, Add Weight-Loss Drug Benefits
Stalled
No legislative action in over 90 days.
Legislative Progress
Key Points
- Medicare could let more providers deliver obesity counseling, not just primary care doctors, as long as care is coordinated with a referring clinician.
- Eligible providers could include nurse practitioners, physician assistants, clinical psychologists, and registered dietitians, plus approved community lifestyle programs.
- Medicare drug plans could be required to cover obesity medications when used to treat obesity, and for some overweight people with related health problems.
- The prescription drug coverage change would start for plan years beginning 2 years after the law is enacted, so it would not be immediate.
- The Health and Human Services Department would have to report to Congress within 1 year of enactment, and then every 2 years, on how implementation is going.
Impact Analysis
Personal Impact
How this policy affects specific groups of people
Milestones
Read twice and referred to the Committee on Finance.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
3 articlesWill Medicare and Medicaid Cover Obesity Drugs?
Lawmakers have introduced the Treat and Reduce Obesity Act of 2025 to mandate Medicare coverage for FDA-approved obesity medications and visits with specialists. The bill would allow a variety of practitioners, including registered dietitians, to provide intensive behavioral therapy.
Medicare to Cover Blockbuster Obesity Drugs
President Trump announced a deal to expand Medicare coverage for semaglutide and tirzepatide for weight management. While the administration is using pilot programs, the Treat and Reduce Obesity Act remains the legislative path to permanently codify these benefits and expand counseling access.
Medicare to Cover Obesity Drugs Under Trump Deal for as Little as $50. What You Need to Know
A landmark deal with pharmaceutical companies will expand Medicare coverage for weight-loss medications starting in mid-2026. This move aligns with goals of the Treat and Reduce Obesity Act, which seeks to modernize Medicare by removing outdated barriers to comprehensive obesity care.
Source Information
Document Type
Congressional Bill
Official Title
Treat and Reduce Obesity Act of 2025
Data Sources
Sponsor
Cosponsors
(22)Analysis generated by AI. Always verify with official sources.